AVI BioPharma in Chiron licensing deal (Hep C Treatment)

AVI BioPharma in Chiron licensing deal
BusinessWeek - JAN. 27 11:51 A.M. ET AVI BioPharma Inc., a biopharmaceutical company, said Friday Chiron Corp. granted AVI a nonexclusive license to Chiron's patents for hepatitis C virus, or HCV, antisense therapeutics drugs. Chronic HCV infection causes liver

January truck market starting strong
Sunday Times South Africa - The SA heavy commercial vehicle (HCV) market started the new sales year on a strong note, substantially exceeding the 12% annual growth rate needed to ensure 2006 becomes a new outright record sales year, Nissan Diesel South Africa notes. The segment

First-Time Generic Approvals: Copegus, Tegretol, Roxicodone
Medscape News - Jan. 24, 2006 The US Food and Drug Administration (FDA) approved in December 2005 first-time generic 200-mg formulations of ribavirin and carbamazepine tablets, and 15- and 30-mg formulations of oxycodone HCl tablets. First-time doses (ie, no